Latest Capital Markets News

TradeWindow is positioning itself for a primary ASX listing, appointing two seasoned Australian logistics experts to its board and reshaping its executive team to deepen market expertise and meet listing requirements.

Pacific Edge’s draft Medicare Local Coverage Determination for its Cxbladder bladder cancer tests marks a pivotal step toward unlocking a $10.2 billion global market. Despite FY26 setbacks, the company is poised for growth with improved reimbursement prospects and strategic cost management.

Finder Energy’s KTJ offshore development in Timor-Leste has achieved a key milestone with an independent classification of 22.2 million barrels of 2P reserves, underpinning its push toward a Final Investment Decision.

Dexus (ASX: DXS) reported steady FY26 results with AFFO of 45.0 cents per security and distributions of 37.0 cents, while initiating a strategic review of infrastructure funds following an adverse APAC court judgment.

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.

Cuscal Limited reported a 49% jump in statutory profit after tax to $42.7 million for FY26, driven by strategic acquisitions of Indue and Paymark that expanded its Australian and New Zealand footprint. The company declared a fully franked 7-cent final dividend and expects mid-twenties percentage growth in underlying profit and transaction volumes for FY27.

Fortescue Ltd delivered a record 201.3 million tonnes of iron ore in FY26, alongside a 3% rise in underlying net profit after tax to US$3.47 billion, despite a significant $750 million impairment charge on its Iron Bridge asset. The miner declared a fully franked final dividend of A$0.46 per share and continues to advance its ambitious decarbonisation and growth agenda.

Heartland Group Holdings delivered a striking 140% jump in net profit for FY2026, underpinned by margin gains and asset quality improvements, while advancing a transformative merger with TSB to create a major New Zealand challenger bank.

NZX Limited reported a robust first half of 2026 with operating earnings up 9.4% and net profit rising 18%. The exchange strengthened its funds management and wealth administration arms, relaunched equity derivatives, and declared a higher interim dividend. A new CEO is set to take the helm in September.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.

Patriot Resources has locked in a $3 million placement to fund exploration at its flagship Tassa silver-gold project in Peru and a new copper discovery in Zambia, underpinning its strategy to grow high-grade mineral resources.

Marquee Resources has launched an eight-hole reverse circulation drilling program at its Yindi Gold Project, focusing on a statistically refined central corridor to test for primary gold mineralisation beneath transported cover.